FDA Recall Open, Classified

Percept BrainSense Implantable Neurostimulator (INS), Model B35200

Recall: Z-1128-2022 · Initiated March 30, 2022

Recall

Recall Number
Z-1128-2022
Event Number
89994
Firm
Medtronic Neuromodulation
FEI Number
2182207
Product Code
MHY
Status
Open, Classified
Root Cause
Under Investigation by firm
Initiated
March 30, 2022
Address
7000 Central Ave Ne, Minneapolis, MN, 55432-3568

Description

Percept BrainSense Implantable Neurostimulator (INS), Model B35200

Reason

The Implantable Neurostimulator (INS) cannot communicate with the clinical programmer and/or the patient programmer system.

Action

A customer letter, dated March 2022, was issued to the impacted consignee via mail. The consignee is instructed to ensure the patient programmer system is set up to communicate with the patient's INS at the patient's initial programming session. If a patient's INS cannot communicate with the clinician programmer and/or patient programmer system, and it is not possible to make therapy adjustments or turn stimulation off, the consignee should contact Medtronic Technical Services at 1-800-707-0933. The consignee is also asked to complete the customer confirmation form and submit to the recalling firm.

Distribution

Worldwide distribution - US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and the countries of Argentina, Australia, Austria, Belgium, Brazil, Canada, Canary Islands, Chile, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Luxembourg, Netherlands, Norway, Poland, Portugal, Slovakia, South Africa, Spain, Sweden, Switzerland, Thailand, United Kingdom.

Quantity

14164 units